These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors. Aoki A, Shibata A. Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342 [Abstract] [Full Text] [Related]
23. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S. Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890 [Abstract] [Full Text] [Related]
24. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Drize N, Chertkov J, Samoilina N, Zander A. Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232 [Abstract] [Full Text] [Related]
27. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S. Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781 [Abstract] [Full Text] [Related]
28. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice. Honda K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Harada M. Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503 [Abstract] [Full Text] [Related]
29. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow. van de Ven C, Ishizawa L, Law P, Cairo MS. Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284 [Abstract] [Full Text] [Related]
30. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone. Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M. Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570 [Abstract] [Full Text] [Related]
33. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P. Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163 [Abstract] [Full Text] [Related]
34. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice. Carlo-Stella C, Di Nicola M, Magni M, Longoni P, Milanesi M, Stucchi C, Cleris L, Formelli F, Gianni MA. Cancer Res; 2002 Nov 01; 62(21):6152-7. PubMed ID: 12414641 [Abstract] [Full Text] [Related]
37. Synergism of interleukin 12, interleukin 3 and serum factor on primitive human hematopoietic progenitor cells. Hirao A, Takaue Y, Kawano Y, Sato J, Suzue T, Abe T, Saito S, Kawahito M, Okamoto Y, Makimoto A. Stem Cells; 1995 Jan 01; 13(1):47-53. PubMed ID: 7536512 [Abstract] [Full Text] [Related]
38. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Biol Blood Marrow Transplant; 2004 Jun 01; 10(6):395-404. PubMed ID: 15148493 [Abstract] [Full Text] [Related]